Ernexa Therapeutics Inc.
ERNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000748592
No open-market purchases or sales by Ernexa Therapeutics Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $236.2K in total; no superinvestor holds it.
Other share classesERNAW
13F holders, Q1 2025
Institutional positions in Ernexa Therapeutics Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +3 vs. Q4 2024
- Shares held
- 1.49M
- +494.0K (+49.7%) vs. Q4 2024
- Total value
- $264.2K
- −$28.2K (−9.6%) vs. Q4 2024
- New holders
- 6
- 7 more added
- Sold out
- 3
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ERNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $236.2K |
| Q1 2026 | 20 | $711.4K |
| Q4 2025 | 14 | $627.1K |
| Q3 2025 | 14 | $566.0K |
| Q2 2025 | 12 | $91.7K |
| Q1 2025 | 27 | $264.2K |
| Q4 2024 | 24 | $292.4K |
| Q3 2024 | 20 | $746.9K |
| Q2 2024 | 20 | $712.4K |
| Q1 2024 | 23 | $981.1K |
| Q4 2023 | 20 | $636.9K |
| Q3 2023 | 22 | $728.4K |
| Q2 2023 | 20 | $750.2K |
| Q1 2023 | 21 | $1.14M |
| Q4 2022 | 20 | $1.19M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Ernexa Therapeutics Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 2 | $0 | 0.00% | +2 | New |
| SBI Securities Co., Ltd. | 10 | $2 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 19 | $3 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 53 | $9 | 0.00% | −6−10.2% | Reduced |
| Activest Wealth Management | 50 | $9 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 140 | $25 | 0.00% | 00.0% | Unchanged |
| Montag A & Associates Inc | 141 | $26 | 0.00% | −71−33.5% | Reduced |
| Bank of America Corp | 309 | $55 | 0.00% | +14+4.7% | Added |
| EverSource Wealth Advisors, LLC | 1,754 | $312 | 0.00% | +1,754 | New |
| Assetmark, Inc | 2,000 | $356 | 0.00% | +2,000 | New |
| one8zero8, LLC | 10,873 | $1.94K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 12,300 | $2.19K | 0.00% | −2,619−17.6% | Reduced |
| UBS Group AG | 12,473 | $2.22K | 0.00% | −4,384−26.0% | Reduced |
| Avidian Wealth Solutions, LLC | 14,798 | $2.63K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 18,050 | $3.21K | 0.00% | +5,237+40.9% | Added |
| Vanguard Group Inc | 38,190 | $6.80K | 0.00% | +12,091+46.3% | Added |
| HRT Financial LP | 42,499 | $7.00K | 0.00% | +42,499 | New |
| XTX Topco Ltd | 41,382 | $7.37K | 0.00% | −16,720−28.8% | Reduced |
| Naviter Wealth, LLC | 47,271 | $8.24K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 65,572 | $11.7K | 0.00% | +65,572 | New |
| JustInvest LLC | 67,623 | $12.0K | 0.00% | +67,623 | New |
| Sippican Capital Advisors | 80,000 | $14.2K | 0.01% | +30,000+60.0% | Added |
| Cypress Point Wealth Management, LLC | 94,375 | $16.8K | 0.01% | 00.0% | Unchanged |
| Citigroup Inc | 153,155 | $27.3K | 0.00% | +153,140+1,020,933.3% | Added |
| Two Sigma Securities, LLC | 229,338 | $40.8K | 0.01% | +199,602+671.2% | Added |
| CI Private Wealth, LLC | 262,862 | $46.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 293,148 | $52.2K | 0.00% | +35,838+13.9% | Added |
| Millennium Management LLC | 0 | $0 | 0.00% | −45,046−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −31,167−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −21,365−100.0% | Sold out |